Aptevo Therapeutics Inc (APVO) USD0.001

Sell:$4.32Buy:$4.59Price increased$0.21 (4.86%)

Prices delayed by at least 15 minutes
Sell:$4.32
Buy:$4.59
Change:Price increased$0.21 (4.86%)
Deal now
Prices delayed by at least 15 minutes
Sell:$4.32
Buy:$4.59
Change:Price increased$0.21 (4.86%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$4.24
Previous close$4.22
Market cap$4.42m
P/E ratio-99999.99
Volume20,192
Dividend yield0.00%
EMS-

Company information

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. The Company has two clinical candidates: Mipletamig and ALG.APV-527. ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue997,830.00
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.